Enliven Therapeutics, Inc. (ELVN) Price History & Returns
How Enliven Therapeutics, Inc. (ELVN) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $41.52 sits 56% of the way up a 52-week range of $14.79 to $62.32; 33.4% below the 52-week high; a beta of 0.24 means it has historically moved less than the market.
Total return
Price change over each trailing period, not annualised.
Year by year
3 of 6 years closed higher than the year before. Closes are the last observation in each calendar year.
Monthly closing prices
The last 36 months, newest first. 20 of 36 months closed higher than the month before. Each figure is the last close in that month.
Enliven Therapeutics, Inc. (ELVN) price history — frequently asked questions
How has Enliven Therapeutics, Inc. performed over the last year?
Enliven Therapeutics, Inc. (ELVN) has risen 184.2% over the last twelve months, measured on price alone.
What is Enliven Therapeutics, Inc.'s five-year return?
Over five years the ELVN share price has gained 214.6%, excluding dividends.
What is Enliven Therapeutics, Inc.'s 52-week range?
Over the last year Enliven Therapeutics, Inc. (ELVN) has traded between $14.79 and $62.32.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.